News Diaceutics PLC

Stocks

DXRX

GB00BJQTGV64

Business Support Services

Market Closed - London S.E. 18:35:11 08/10/2026 +03			5-day change	1st Jan Change
202.00 ^GBX	+1.00%		+5.48%	+57.81%

09-24	Diaceutics PLC And Syndax Pharmaceuticals, Inc. Expand Multi-Year Relay Partnership	CI
09-22	EARNINGS: Origin Enterprises beats operating profit target	AN

All News

Mentions Relevance

09-24	Diaceutics PLC And Syndax Pharmaceuticals, Inc. Expand Multi-Year Relay Partnership	CI
09-22	Diaceutics PLC Reports Earnings Results for the Half Year Ended June 30, 2026	CI
09-22	Earnings Flash (DXRX.L) Diaceutics PLC Reports H1 Revenue GBP17.5M	MT
08-20	Diaceutics and Precision Cancer Consortium Launch Ngs Concordance Study to Advance Precision Oncology and Support Informed Biomarker Testing	CI
07-29	Diaceutics PLC Reports Revenue Results for the Half Year Ended 30 June 2026	CI
06-02	Diaceutics PLC, 2025 Earnings Call, May 26, 2026
05-26	Diaceutics PLC Reports Earnings Results for the Full Year Ended December 31, 2025	CI
05-26	Diaceutics says order book and pipeline provides confidence for 2026	AN
05-26	Diaceutics says Q1 2026 performance in line with board's expectations	RE
05-26	Earnings Flash (DXRX.L) Diaceutics PLC Reports FY25 Revenue GBP38.4M	MT
01-15	Diaceutics PLC Provides Earnings Guidance for the Year Ended December 31, 2025 and Fiscal Year 2026	CI
01-15	Diaceutics expects to deliver 25% revenue growth in FY26	RE
23/09/25	Diaceutics PLC Reports Earnings Results for the Half Year Ended June 30, 2025	CI
29/07/25	Diaceutics PLC Appoints Lauren Dewitt as Executive Vice President, Legal, General Counsel, and Group Company Secretary	CI
22/07/25	Diaceutics stock rises on "strong" first half and contract expansion	AN
22/07/25	Diaceutics reports 22% revenue growth to £14.6 mln in HY	RE
17/07/25	Diaceutics plc Expands PMx Commercialization Partnership Contract	CI
19/05/25	Diaceutics chair sells 500,000 shares after results release	AN
16/05/25	Diaceutics plc Announces Termination of Sally Craig as Secretary or Corporate Secretary, Effective May 5, 2025	CI
13/05/25	Diaceutics narrows loss, grows revenue in "another strong year"	AN
13/05/25	Diaceutics Says Do Not Expect Direct Impact From Recent Tariff Announcements	RE
13/05/25	Earnings Flash (DXRX.L) DIACEUTICS Reports FY24 Revenue GBP32.2M	MT
13/05/25	Earnings Flash (DXRX.L) DIACEUTICS Reports FY24 Loss GBX-2.02	MT
13/05/25	Diaceutics PLC, 2024 Earnings Call, May 13, 2025
13/05/25	Diaceutics PLC Reports Earnings Results for the Full Year Ended December 31, 2024	CI